Union Springs Pharmaceutical launches the only non-alcohol first response
protection product that can be sprayed on the face.
ORLANDO, Fla., Oct. 10 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today at the annual EMS EXPO that it is marketing a new revolutionary product, MyClyns(TM). MyClyns is the first product of its kind to be made available to first responders who need to protect themselves in the field when exposed to harmful pathogens. The product, a small pen-sized non- aerosol spray device that can be kept in a pocket, is convenient and safe to use on the face and mucous membranes including the eyes, ears, nose, mouth, and skin. In addition, MyClyns is a fast-acting skin protectant that kills over 99.99% of germs on contact as demonstrated in independent laboratory tests. MyClyns also provides immediate efficacy after one application (>99% bacterial reduction) and passed the initial reduction criteria for the Health Care Personnel Handwash Test.
MyClyns contains a pH neutral, non-irritating solution of compounds that are similar to the chemicals produced by the human body in its defense against microorganisms. These compounds move through the pathogen's cells and deactivate essential enzymes and structures.
MyClyns allows first responders to protect themselves immediately after exposure to harmful pathogens while still attending to their care recipients. Since users can protect themselves immediately, they lower their risk associated with prolonged exposure. Because of its unique and convenient design, MyClyns can be used with only one hand. MyClyns is intended for use by police, fire, military, emergency medical personnel, healthcare providers, homeland security personnel and others.
Union Springs licensed worldwide rights to the Microcyn(R) Technology used in MyClyns for single-use first responder applications from Oculus Innovative Sciences, Inc. (Petaluma, CA) in June of this year.
"Our team at Union Springs is excited to be launching MyClyns at this year's EMS EXPO" said Roger Griggs, Chairman of Union Springs Pharmaceuticals. "We believe we have a truly unique product that first responders will use in situations where today there is nothing else available. We are happy to advance the science of personal protection and we hope that MyClyns will become the standard of care for first line responders after exposures where immediate attention is required," he added.
About Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals, located in Union, KY, specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. The company licenses, acquires, develops and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals was formed by the Drug Enhancement Company of America (DECA) to commercialize products specifically targeted for the OTC market. DECA and members of its management team have developed both prescription and over-the-counter healthcare products and services and companies including Richwood Pharmaceuticals (now Shire), Xanodyne Pharmaceuticals, Integrity Pharmaceuticals, PediaMed and Hill Top Research. For more information about DECA, please visit http://www.decausa.com. Union Springs Pharmaceuticals can be found on the Internet at http://www.unionspringspharmaceuticals.com
Microcyn(R) is a registered trademark of Oculus Innovative Sciences, Inc.
|SOURCE Union Springs Pharmaceuticals, LLC|
Copyright©2007 PR Newswire.
All rights reserved